Factory high quality and low price 3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine
| Price | USD1.00 |
| Packge | 1KG |
- Min. Order:1KG
- Supply Ability:g/kg/Ton
- Time:2019-12-26
Product Details
- Product Name3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine
- CAS No.641571-16-6
- MFC11H10F3N3
- MW241.22
- AppearanceSolidWhite to Pale Red
- Melting point 131-133oC
- storage temp. Hygroscopic, Refrigerator, under inert atmosphere
Heidi 0775
Email:heidi@coreychem.com
▼
▲
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine Basic information
▼
▲
Synonyms:
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine;3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)aniline;3-(5-methylimidazol-1-yl)-5-(trifluoromethyl)aniline
CAS:
MF:
C11H10F3N3
MW:
241.2124096
EINECS:
Product Categories:
Mol File:
▼
▲
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine Chemical Properties
▼
▲
▼
▲
Safety Information
▼
▲
▼
▲
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine Usage And Synthesis
▼
▲
Uses
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine is used in the preparation of c-Src and Abl inhibitors based on the scaffold present in Imatinib (G407000), used in the treatment of myelogenic leukemia.
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
-
VIP1年
- Raising Sun Pharma
- 641571-11-1 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Sai Life Sciences Ltd
- 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 641571-11-1 98%
- Inquiry
- 2024-01-23
-
VIP1年
- Lakshmi Farmachem
- 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 98%
- Inquiry
- 2024-01-11
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY